Clinical Trials Directory

Trials / Completed

CompletedNCT01594658

Venous Ulcer Treatment With Foam Versus Conservative Treatment

Prospective Random Study for Handling Venous Ulcer With Conservative Treatment (Dressings Alone) and Foam Sclerotherapy Versus Conservative Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Hospital Occidente de Kennedy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The venous ulcer due to venous insufficiency causes an important morbility to those people suffering from this condition. Most of therapies available under the obligatory health plan (POS, acronym in spanish) to date cover the cleaning of the ulcerous lesion and its medical handling using saline solutions, topical antibiotics and elastic dressings, implying an important intake from health resources due to its chronicity and the delay in ulcers healing, which usually takes periods ranging from 6 months to several years. therapeutical alternatives, which can guarantee optimal, fast and persistent in time healings, should be identified. The aim of this study is to determine the percentage of healing of active venous ulcers (using a clinical, etiological, anatomic and physiopathologic classification (CEAP), C6) following ultrasound-guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration after six months from the intervention, compared with conservative medical handling. The investigators expect that the ultrasound-guided foam sclerotherapy of superficial venous reflux will diminish the time of ulcer healing compared with standard handling.

Detailed description

to determine healing rates following ultrasound-guided foam sclerotherapy (UGFS) of superficial venous reflux (SVR) in patients with open (clinical,etiologic, anatomic and pathophysiologic (CEAP) classification, C6) chronic venous ulceration ( CVU) in a randomised clinical trial of foam sclerotherapy for patients with venous ulcer

Conditions

Interventions

TypeNameDescription
PROCEDUREFoam sclerotherapyFoam application of 1% (Sklerol®, ICV Pharma, Bogota-Colombia), Reg INVIMA: 2002M-0001016, guided by ecography of insufficient superficial veins, doses from 10-40 cc of foam until obtaining endoluminal occlusion of the vein. The patient will rest for 8 minutes and then the leg will be covered with elastic bandage.
PROCEDUREconservativeThis arm only has medical standard handling (healings performed by the nurse group)

Timeline

Start date
2011-07-01
Primary completion
2012-02-01
Completion
2012-09-01
First posted
2012-05-09
Last updated
2012-10-02

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT01594658. Inclusion in this directory is not an endorsement.